Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...

Ola Engkvist is the Executive Director and Head of Molecular AI in Discovery Sciences within R&D at AstraZeneca (headquartered in Cambridge, UK). His team harnesses advanced computational technologies ...

A new paper in Nature Biotechnology published March 8 offers the first in-depth look at how AI-driven biotech Insilico Medicine used artificial intelligence to discover, develop and test its lead drug ...

From idea, to lab, to clinic, to approval—it's a long and expensive process to bring a drug to market. It also rarely ...

In the face of US federal funding cuts, biomedical researchers propose strategies for continued progress in drug discovery.

About 30% of all respiratory tract infections are caused by coronaviruses, leading to widespread illnesses and, in some cases, to epidemic and even pandemic outbreaks, as we experienced with the COVID ...

The average drug now costs more than US$1 billion to develop and takes more than a decade to reach the market 1. And for every success, there are nine drug candidates that fail clinical trials 2. “In ...

Generative AI based on Large Language Models (LLMs), the technology behind popular tools like ChatGPT and Google Gemini, is revolutionizing various industries, including the world of drug discovery.

For decades, researchers have sought a fast track to drug discovery. Yet the process has been getting slower, as well as riskier and more costly. It generally takes 12–15 years from the initiation of ...

We know the scientific method to be sequential and empirical: Ask, observe, hypothesize. Test, analyze, report. And then do it all over again, and again, and again. For better or worse, that sequence ...

In this White Paper, MatTek, now part of Sartorius, details a highly differentiated 3D small-intestine tissue model that uses ...

Recursion Pharmaceuticals RXRX is redefining the traditional model of drug discovery by harnessing the power of artificial intelligence (AI) through its proprietary RecursionOS platform, developed in ...